Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Deferred Taxes (2019 - 2022)

Historic Deferred Taxes for Pulmonx (LUNG) over the last 4 years, with Q4 2022 value amounting to -$49000.0.

  • Pulmonx's Deferred Taxes fell 38823.53% to -$49000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$49000.0, marking a year-over-year decrease of 91666.67%. This contributed to the annual value of $50000.0 for FY2024, which is 30833.33% up from last year.
  • According to the latest figures from Q4 2022, Pulmonx's Deferred Taxes is -$49000.0, which was down 38823.53% from $17000.0 recorded in Q4 2021.
  • Pulmonx's 5-year Deferred Taxes high stood at $17000.0 for Q4 2021, and its period low was -$49000.0 during Q4 2022.
  • In the last 4 years, Pulmonx's Deferred Taxes had a median value of -$10000.0 in 2021 and averaged -$10555.6.
  • In the last 5 years, Pulmonx's Deferred Taxes skyrocketed by 24166.67% in 2021 and then tumbled by 38823.53% in 2022.
  • Over the past 4 years, Pulmonx's Deferred Taxes (Quarter) stood at -$30000.0 in 2019, then skyrocketed by 60.0% to -$12000.0 in 2020, then skyrocketed by 241.67% to $17000.0 in 2021, then crashed by 388.24% to -$49000.0 in 2022.
  • Its last three reported values are -$49000.0 in Q4 2022, $17000.0 for Q4 2021, and -$1000.0 during Q2 2021.